Vontobel Holding
IMUX icon

Vontobel Holding’s Immunic IMUX Stock Holding History

Vontobel Holding’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,000
Closed -$13.2K – 1116
2024
Q1 		$13.2K Buy
+1,000
New +$13K ﹤0.01% 1078
2023
Q3 		– Sell
-1,000
Closed -$25.1K – 1102
2023
Q2 		$25.1K Buy
+1,000
New +$16.8K ﹤0.01% 1088

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vontobel Holding's IMUX Position: Q2 2024 in Review

Vontobel Holding sold out of Immunic (IMUX) in Q2 2024, closing a stake of 1,000 shares — an estimated $13.2K sold.

Vontobel Holding first reported a position in IMUX in Q2 2023 and held it in 2 quarters. The position peaked at $25.1K in Q2 2023. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2024.

  • Vontobel Holding reported no remaining Immunic position as of Q2 2024 after selling out during the quarter.
  • Vontobel Holding sold 1,000 Immunic shares in Q2 2024, an estimated $13.2K.
  • Vontobel Holding first reported a position in Immunic in Q2 2023 and held it in 2 quarters.
  • Vontobel Holding's Immunic position peaked at $25.1K in Q2 2023.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2024.

Based on Vontobel Holding's 13F filing for Q2 2024, filed 13 Aug 2024.